Your search resulted in multiple matches. Please select a position:

Gencode Genes

GAP43 (ENST00000305124.10) at chr3:115623324-115721490 - Homo sapiens growth associated protein 43 (GAP43), transcript variant 2, mRNA. (from RefSeq NM_002045)
GAP43 (ENST00000393780.3) at chr3:115623510-115721490 - Homo sapiens growth associated protein 43 (GAP43), transcript variant 1, mRNA. (from RefSeq NM_001130064)
ZDHHC2 (ENST00000262096.13) at chr8:17156482-17224799 - Homo sapiens zinc finger DHHC-type containing 2 (ZDHHC2), transcript variant 1, mRNA. (from RefSeq NM_016353)
ZDHHC15 (ENST00000541184.1) at chrX:75368431-75523502 - Homo sapiens zinc finger DHHC-type containing 15 (ZDHHC15), transcript variant 2, mRNA. (from RefSeq NM_001146256)
ZDHHC15 (ENST00000373367.8) at chrX:75368427-75523037 - Homo sapiens zinc finger DHHC-type containing 15 (ZDHHC15), transcript variant 1, mRNA. (from RefSeq NM_144969)
LYPLA2 (ENST00000374514.8) at chr1:23791145-23795539 - Homo sapiens lysophospholipase 2 (LYPLA2), mRNA. (from RefSeq NM_007260)
FRS2 (ENST00000550389.5) at chr12:69470406-69579782 - Homo sapiens fibroblast growth factor receptor substrate 2 (FRS2), transcript variant 8, mRNA. (from RefSeq NM_001278357)
FRS2 (ENST00000549921.5) at chr12:69470375-69574964 - Homo sapiens fibroblast growth factor receptor substrate 2 (FRS2), transcript variant 1, mRNA. (from RefSeq NM_006654)
CDH2 (ENST00000399380.7) at chr18:27951081-28036585 - Homo sapiens cadherin 2 (CDH2), transcript variant 2, mRNA. (from RefSeq NM_001308176)
CDH2 (ENST00000269141.8) at chr18:27950966-28177130 - Homo sapiens cadherin 2 (CDH2), transcript variant 1, mRNA. (from RefSeq NM_001792)
FRS2 (ENST00000397997.6) at chr12:69557789-69579789 - Adapter protein that links activated FGR and NGF  receptors to downstream signaling pathways. Plays an important  role in the activation of MAP kinases and in the phosphorylation  of PIK3R1, the regulatory subunit of phosphatidylinositol 3-  kinase, in response to ligand-mediated activation of FGFR1.  Modulates signaling via SHC1 by competing for a common binding  site on NTRK1. (from UniProt Q8WU20)
CTTN (ENST00000376561.7) at chr11:70398541-70436579 - Homo sapiens cortactin (CTTN), transcript variant 3, mRNA. (from RefSeq NM_001184740)
CTTN (ENST00000346329.7) at chr11:70398404-70436584 - Homo sapiens cortactin (CTTN), transcript variant 2, mRNA. (from RefSeq NM_138565)
CTTN (ENST00000301843.13) at chr11:70398529-70436575 - Homo sapiens cortactin (CTTN), transcript variant 1, mRNA. (from RefSeq NM_005231)
PHKG2 (ENST00000563588.6) at chr16:30748425-30761176 - Homo sapiens phosphorylase kinase catalytic subunit gamma 2 (PHKG2), transcript variant 1, mRNA. (from RefSeq NM_000294)
PHKG2 (ENST00000424889.7) at chr16:30748299-30760391 - Homo sapiens phosphorylase kinase catalytic subunit gamma 2 (PHKG2), transcript variant 2, mRNA. (from RefSeq NM_001172432)
SHC1 (ENST00000368450.5) at chr1:154962298-154974376 - Homo sapiens SHC adaptor protein 1 (SHC1), transcript variant 5, mRNA. (from RefSeq NM_001202859)
SHC1 (ENST00000448116.6) at chr1:154962298-154970747 - Homo sapiens SHC adaptor protein 1 (SHC1), transcript variant 3, mRNA. (from RefSeq NM_001130040)
SHC1 (ENST00000368453.8) at chr1:154962298-154974376 - Homo sapiens SHC adaptor protein 1 (SHC1), transcript variant 2, mRNA. (from RefSeq NM_003029)
SHC1 (ENST00000368445.9) at chr1:154962298-154970741 - Homo sapiens SHC adaptor protein 1 (SHC1), transcript variant 1, mRNA. (from RefSeq NM_183001)
FGFR4 (ENST00000393637.5) at chr5:177089567-177097769 - Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 2, mRNA. (from RefSeq NM_022963)
FGFR4 (ENST00000292408.9) at chr5:177086915-177098144 - Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 3, mRNA. (from RefSeq NM_213647)
FGFR4 (ENST00000502906.5) at chr5:177086914-177097732 - Tyrosine-protein kinase that acts as cell-surface  receptor for fibroblast growth factors and plays a role in the  regulation of cell proliferation, differentiation and migration,  and in regulation of lipid metabolism, bile acid biosynthesis,  glucose uptake, vitamin D metabolism and phosphate homeostasis.  Required for normal down-regulation of the expression of CYP7A1,  the rate-limiting enzyme in bile acid synthesis, in response to  FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the  activation of several signaling cascades. Activation of PLCG1  leads to the production of the cellular signaling molecules  diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation  of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and  mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP  kinase signaling pathway, as well as of the AKT1 signaling  pathway. Promotes SRC-dependent phosphorylation of the matrix  protease MMP14 and its lysosomal degradation. FGFR4 signaling is  down-regulated by receptor internalization and degradation; MMP14  promotes internalization and degradation of FGFR4. Mutations that  lead to constitutive kinase activation or impair normal FGFR4  inactivation lead to aberrant signaling. (from UniProt P22455)
PRKCD (ENST00000652449.1) at chr3:53161217-53192487 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 7, mRNA. (from RefSeq NM_001354680)
PRKCD (ENST00000650739.1) at chr3:53161356-53192558 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 6, mRNA. (from RefSeq NM_001354679)
PRKCD (ENST00000394729.6) at chr3:53161120-53192717 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 2, mRNA. (from RefSeq NM_212539)
PRKCD (ENST00000330452.8) at chr3:53161209-53192717 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 1, mRNA. (from RefSeq NM_006254)
SRC (ENST00000373578.6) at chr20:37346154-37406050 - Homo sapiens SRC proto-oncogene, non-receptor tyrosine kinase (SRC), transcript variant 2, mRNA. (from RefSeq NM_198291)
SRC (ENST00000373567.6) at chr20:37383668-37406050 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)
SRC (ENST00000373558.2) at chr20:37384150-37406050 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)
SRC (ENST00000358208.8) at chr20:37382604-37405432 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_002045.4 at chr3:115623510-115721483
NM_001130064.2 at chr3:115623510-115721483

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_017006128.1 at chr3:115661856-115721485

RefSeq Genes

GAP43 at chr3:115623510-115721483 - (NM_001130064) neuromodulin isoform 1
GAP43 at chr3:115623510-115721483 - (NM_002045) neuromodulin isoform 2

Non-Human RefSeq Genes

GAP43 at chr3:115623496-115721483 - (NM_001244335) neuromodulin
GAP43 at chr3:115623541-115721422 - (NM_001323489) growth associated protein 43
gap43 at chr3:115623675-115721389 - (NM_001078744) neuromodulin
GAP43 at chr3:115623603-115721485 - (NM_001283770) neuromodulin
GAP43 at chr3:115623614-115721423 - (NM_001133604) neuromodulin
GAP43 at chr3:115623633-115721047 - (NM_001305054) neuromodulin
GAP43 at chr3:115623690-115720882 - (NM_001009816) neuromodulin
GAP43 at chr3:115623650-115721047 - (NM_001009303) neuromodulin
Gap43 at chr3:115623495-115721483 - (NM_017195) neuromodulin
Gap43 at chr3:115623540-115721361 - (NM_008083) neuromodulin
GAP43 at chr3:115623540-115721490 - (NM_203358) neuromodulin

Basic Gene Annotation Set from GENCODE Version 33 (Ensembl 99)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 33 (Ensembl 99)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

GAP43 at chr3:115623324-115721490
GAP43 at chr3:115623510-115721490

International Knockout Mouse Consortium Genes Mapped to Human Genome

Gap43_38575 at chr3:115623304-115721487
Gap43_38576 at chr3:115623304-115721487
Gap43_38577 at chr3:115623304-115721487

Alias of STS Marker

GAP43 at chr3:115620883-115821305 - (WI-7159)

Human Aligned mRNA Search Results

BC007936 - Homo sapiens growth associated protein 43, mRNA (cDNA clone MGC:14099 IMAGE:4126520), complete cds.
M25667 - Human neuronal growth protein 43 (GAP-43) mRNA, complete cds.
AK313658 - Homo sapiens cDNA, FLJ94238, Homo sapiens growth associated protein 43 (GAP43), mRNA.

Non-Human Aligned mRNA Search Results

BC165904 - Danio rerio growth associated protein 43, mRNA (cDNA clone MGC:192992 IMAGE:100061486), complete cds.
AY195838 - Bos taurus GAP43 mRNA, complete cds.
EF410135 - Mus musculus Accn1/Gap43 trans-spliced mRNA sequence.
AF481882 - Felis catus growth associated protein 43 (GAP43) mRNA, partial cds.
AY462113 - Felis catus neuron growth-associated protein 43 (GAP43) mRNA, complete cds.
BC118452 - Bos taurus growth associated protein 43, mRNA (cDNA clone MGC:140756 IMAGE:8276270), complete cds.
AY888673 - Synthetic construct Homo sapiens clone FLH010142.01X growth associated protein 43 (GAP43) mRNA, complete cds.
AY888674 - Synthetic construct Homo sapiens clone FLH010143.01X growth associated protein 43 (GAP43) mRNA, complete cds.
AY891317 - Synthetic construct Homo sapiens clone FLH010138.01L growth associated protein 43 (GAP43) mRNA, partial cds.
AY891318 - Synthetic construct Homo sapiens clone FLH010139.01L growth associated protein 43 (GAP43) mRNA, partial cds.
JU322581 - TSA: Macaca mulatta Mamu_511342 mRNA sequence.
AB274830 - Capra hircus Gap43 mRNA for growth associated protein 43, partial cds.
BC028288 - Mus musculus growth associated protein 43, mRNA (cDNA clone MGC:25402 IMAGE:4503501), complete cds.
BC080758 - Mus musculus growth associated protein 43, mRNA (cDNA clone MGC:91069 IMAGE:5363932), complete cds.
BC127502 - Rattus norvegicus growth associated protein 43, mRNA (cDNA clone MGC:156666 IMAGE:8364847), complete cds.
AB173479 - Macaca fascicularis brain cDNA clone: QflA-22738, similar to human growth associated protein 43 (GAP43), mRNA, RefSeq: NM_002045.2.
AB169784 - Macaca fascicularis brain cDNA, clone: QtrA-13071, similar to human growth associated protein 43 (GAP43), mRNA, RefSeq: NM_002045.2.
AB063093 - Macaca fascicularis brain cDNA clone:QtrA-11580, similar to human growth associated protein 43 (GAP43), mRNA, NM_002045.1.